Shinkai Y, Cameron J S
Department of Medicine, United Medical School, London, UK.
Nephron. 1987;47(3):211-9. doi: 10.1159/000184495.
Accelerated anti-glomerular basement membrane nephritis was induced in rabbits, and the immunological, clinical and histological evolution studied in relation to urinary immunoreactive thromboxane B2 (i-TXB2) and immunoreactive prostaglandin E2 (i-PGE2) excretion. In control nephritic animals, urinary i-TXB2 increased 5-fold on day +1, but was normal again by day +5. The urinary i-TXB2 showed a positive correlation with creatinine clearance (CCr), proteinuria and anti-sheep immunoglobulin antibody. Urinary i-PGE2 excretion increased by 50% on day +1, but was indistinguishable later from controls. The effects of the specific thromboxane synthetase inhibitor OKY-046 on this model was studied. In non-nephritic control animals, OKY-046 did not affect the CCr, the urinary protein excretion or the number of monocytes in glomeruli but reduced the excretion of i-TXB2. Although OKY-046 markedly inhibited the i-TXB2 excretion throughout the experiment in nephritic animals, the creatinine clearances were significantly worse, the proteinuria greater, and the number of infiltrating monocytes greater at day +5; by day +10 there was no difference from controls. There was no evidence that TXB2 is involved in the induction of proteinuria, and increased PGE2 synthesis did not protect against later proteinuria and fall in creatinine clearance. Inhibition of thromboxane synthetase appears to make this model of nephritis worse, rather than better.
在兔身上诱导出加速性抗肾小球基底膜肾炎,并研究其免疫、临床和组织学演变与尿免疫反应性血栓素B2(i-TXB2)和免疫反应性前列腺素E2(i-PGE2)排泄的关系。在对照性肾炎动物中,尿i-TXB2在第1天增加了5倍,但在第5天时又恢复正常。尿i-TXB2与肌酐清除率(CCr)、蛋白尿和抗绵羊免疫球蛋白抗体呈正相关。尿i-PGE2排泄在第1天增加了50%,但之后与对照组无差异。研究了特异性血栓素合成酶抑制剂OKY-046对该模型的影响。在非肾炎对照动物中,OKY-046不影响CCr、尿蛋白排泄或肾小球内单核细胞数量,但降低了i-TXB2的排泄。尽管在肾炎动物实验中,OKY-046在整个实验过程中显著抑制了i-TXB2的排泄,但在第5天时肌酐清除率明显更差,蛋白尿更多,浸润的单核细胞数量更多;到第10天时与对照组无差异。没有证据表明TXB2参与蛋白尿的诱导,且PGE2合成增加并不能预防后期的蛋白尿和肌酐清除率下降。抑制血栓素合成酶似乎使这种肾炎模型恶化,而非改善。